CLSI M57-Ed1 (R2022)

Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing

Clinical and Laboratory Standards Institute, 04/25/2016

Publisher: CLSI

File Format: PDF

$90.00$180.00

Description

Published:25/04/2016

Pages:28

File Size:1 file , 2 MB

Note:This product is unavailable in Russia, Belarus

This guideline includes the criteria for developing and using epidemiological cutoff values for guiding clinical decisions when testing fungal species and antifungal agent combinations for which there are no breakpoints.

More CLSI standard pdf

CLSI MM05A

Nucleic Acid Amplification Assays for Molecular Hematopathology; Approved Guideline, MM05-A

$103.00 $206.29

CLSI LIS09-A

Standard Guide for Coordination of Clinical Laboratory Services Within the Electronic Health Record Environment and Networked Architectures, LIS9AE

$138.00 $277.36

CLSI LIS06-A

Standard Practice for Reporting Reliability of Clinical Laboratory Information Systems, LIS6AE

$139.00 $278.67

CLSI M24A

Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard, M24-A

$135.00 $271.99